Case-control study of giant coronary aneurysms due to Kawasaki disease: The 19th nationwide survey

Pediatrics International

Volumn 52, Issue 5, 2010, Pages 790-794

  Sudo, Daisuke ^a   Monobe, Yoshiro ^a   Yashiro, Mayumi ^a   Sadakane, Atsuko ^a   Uehara, Ritei ^a   Nakamura, Yosikazu ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

case control studies; coronary aneurysm; epidemiology; immunoglobulins; intravenous; mucocutaneous lymph node syndrome

Indexed keywords

IMMUNOGLOBULIN; STEROID;

ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; FEMALE; HEALTH SURVEY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

AGE DISTRIBUTION; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMORBIDITY; CORONARY ANEURYSM; CORONARY ANGIOGRAPHY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INCIDENCE; INFANT; JAPAN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTIVARIATE ANALYSIS; POPULATION SURVEILLANCE; PROGNOSIS; REFERENCE VALUES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 77957365000     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2010.03161.x     Document Type: Article

References (21)

1. Nakamura Y, Yashiro M, Uehara R, Oki I, Kayaba K, Yanagawa H. Increasing incidence of Kawasaki disease in Japan: Nationwide survey. Pediatr. Int. 2008 50 : 287 290.
2. Nakamura Y, Yashiro M, Uehara R, Oki I, Watanabe M, Yanagawa H. Epidemiologic features of Kawasaki disease in Japan: Results from the nationwide survey in 2005-06. J. Epidemiol. 2008 18 : 167 172.
3. Kato H, Sugimura T, Akagi T et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996 94 : 1379 1385.
4. Suzuki N, Seguchi M, Kouno C, Inukai K, Kito H, Kobayashi H. Rupture of coronary aneurysm in Kawasaki disease. Pediatr. Int. 1999 41 : 318 320.
5. Yanagawa H, Nakamura Y, Yashiro M, Ojima T, Koyanagi H, Kawasaki T. Update of the epidemiology of Kawasaki disease in Japan - from the results of 1993-94 nationwide survey. J. Epidemiol. 1996 6 : 148 157. (Pubitemid 126839368)
6. Yanagawa H, Nakamura Y, Yashiro M et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics 2001 107 : 1 4.
7. Yanagawa H, Nakamura Y, Yashiro M, Uehara R, Oki I, Kayaba K. Incidence of Kawasaki disease in Japan: The nationwide surveys of 1999-2002. Pediatr. Int. 2006 48 : 356 361.
8. Furusho K, Kamiya T, Nakano H et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 1984 2 : 1055 1058.
9. Newburger JW, Takahashi M, Burns JC et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N. Engl. J. Med. 1986 315 : 341 347.
10. Newburger JW, Takahashi M, Beiser AS et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N. Engl. J. Med. 1991 324 : 1633 1639.
11. Nakamura Y, Yashiro M, Uehara R et al. Case-control study of giant coronary aneurysms due to Kawasaki disease. Pediatr. Int. 2003 45 : 410 413.
12. Harada K. Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr. Jpn. 1991 33 : 805 810.
13. Sato N, Sugimura T, Akagi T et al. Selective high dose γ-globulin treatment in Kawasaki disease: Assessment of clinical aspects and cost effectiveness. Pediatr. Int. 1999 41 : 1 7.
14. Harnden A, Alves B, Sheikh A. Rising incidence of Kawasaki disease in England: Analysis of hospital admission data. BMJ 2002 324 : 1424 1425.
15. Holman RC, Curns AT, Belay ED, Steiner CA, Schonberger LB. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics 2003 112 : 495 501.
16. Park YW, Han JW, Park IS et al. Kawasaki disease in Korea, 2003-05. Pediatr. Infect. Dis. J. 2007 26 : 821 823.
17. Muta H, Ishii M, Sakaue T et al. Older age is a risk factor for the development of cardiovascular sequelae in Kawasaki disease. Pediatrics 2004 114 : 751 754.
18. Kavey RE, Allada V, Daniels SR et al. Cardiovascular risk reduction in high-risk pediatric patients: A scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics. Circulation 2006 114 : 2710 2738.
19. Newburger JW, Sleeper LA, McCrindle BW et al. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N. Engl. J. Med. 2007 356 : 663 675.
20. Jibiki T, Terai M, Kurosaki T et al. Efficacy of intravenous immune globulin therapy combined with dexamethasone for the initial treatment of acute Kawasaki disease. Eur. J. Pediatr. 2004 163 : 229 233.
21. Inoue Y, Okada Y, Shinohara M et al. A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: Clinical course and coronary artery outcome. J. Pediatr. 2006 149 : 336 341.